1-8 of 8
Connie L. Erickson-Miller, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Investigating Effects of Cyclosporine on Eltrombopag Pharmacokinetics in Healthy Volunteers: A Phase 1 Crossover, Drug-Drug Interaction Study

Jianping Zhang, PhD, Connie L. Erickson-Miller, PhD, Geoffrey Chan, MD, Yan Yan Zhou, PhD
Journal: Blood
Blood (2015) 126 (23): 4791.
https://doi.org/10.1182/blood.V126.23.4791.4791
Published: 2015
Journal Articles

Eltrombopag, but Not Romiplostim or Thrombopoietin, Inhibits Growth of Thrombopoietin Receptor Positive and Negative Human Leukemia Cell Lines

David W. Rusnak, Sharon K. Rudolph, Afshin Safavi, PhD, Connie L. Erickson-Miller, PhD
Journal: Blood
Blood (2012) 120 (21): 4726.
https://doi.org/10.1182/blood.V120.21.4726.4726
Published: 2012
Journal Articles

DYRK3 Encodes an Inhibitor of Erythroid Differentiation and Is Expressed at High Levels in Patients with Anemia.

David P. Steensma, MD, Julie C. Porcher, BS, Antony Chadderton, MS, Kevin Laubscher, MS, Deb Jaworski, PhD, Joanne J. Lager, MD, William Bell, MS, JD, Bryan E. Hoffman, PhD, Connie L. Erickson-Miller, PhD
Journal: Blood
Blood (2007) 110 (11): 3661.
https://doi.org/10.1182/blood.V110.11.3661.3661
Published: 2007
Journal Articles

The Characterization of DYRK3 mRNA and the Utility of DYRK3 Inhibitors in a Carboplatin/Radiation Mouse Model of Anemia.

Connie L. Erickson-Miller, PhD, Ying Homan, BA, Matthew Chomo, BS, Elizabeth I. Valoret, MS, Louis Elefante, BA, Amy Landis, MS, Antony Chadderton, MS, Christopher B. Hopson, BA
Journal: Blood
Blood (2007) 110 (11): 2202.
https://doi.org/10.1182/blood.V110.11.2202.2202
Published: 2007
Journal Articles

GSK626616: A DYRK3 Inhibitor as a Potential New Therapy for the Treatment of Anemia.

Connie L. Erickson-Miller, PhD, Caretha Creasy, PhD, Antony Chadderton, MS, Christopher B. Hopson, BS, Elizabeth I. Valoret, MS, Michele Gorczyca, MS, Louis Elefante, BA, Don M. Wojchowski, PhD, Matthew Chomo, MS, Duke M. Fitch, PhD, Kevin J. Duffy, PhD
Journal: Blood
Blood (2007) 110 (11): 510.
https://doi.org/10.1182/blood.V110.11.510.510
Published: 2007
Journal Articles

Eltrombopag Decreases Proliferation of Human Leukemia and Lymphoma Cell Lines In Vitro.

Connie L. Erickson-Miller, PhD, Parrish L. Payne, Sherri Moore, Sherryann Wert, Richard D. May
Journal: Blood
Blood (2007) 110 (11): 4089.
https://doi.org/10.1182/blood.V110.11.4089.4089
Published: 2007
Journal Articles

Species Specificity and Receptor Domain Interaction of a Small Molecule TPO Receptor Agonist.

Connie L. Erickson-Miller, PhD, Evelyn Delorme, PHD, Maya Iskander, Leslie Giampa, Christpher B. Hopson, Juan Luengo, PhD, Kevin Duffy, PhD, Susan B. Dillon, PhD, Jon Rosen, PhD, Stephen Miller, PhD, Peter Lamb, PhD, Shin-Shay Tian, PhD
Journal: Blood
Blood (2004) 104 (11): 2909.
https://doi.org/10.1182/blood.V104.11.2909.2909
Published: 2004
Journal Articles

SB 497115-GR, a Low Molecular Weight TPOR Agonist, Does Not Induce Platelet Activation or Enhance Agonist-Induced Platelet Aggregation in Vitro.

Joseph Erhardt, PhD, Connie L. Erickson-Miller, PhD, Peter Tapley, PhD
Journal: Blood
Blood (2004) 104 (11): 3888.
https://doi.org/10.1182/blood.V104.11.3888.3888
Published: 2004